Tag: Trading Exchange Traded Funds

(Source: Google Images) India will be the world’s fastest growing economy in 2019 with an expected growth rate of 7.3%, according to the IMF. The GDP of India has almost doubled post the global financial crisis and is likely to double again to become $5 trillion in the next decade. The current bull run in India is led by sectors like FMCG, consumption, automobiles and financial services. Most of the companies in these sectors are high quality in nature with high visibility of quarterly earnings; many investors and fund managers…

Major Moves  Tensions between the U.S. and Iran following the attacks on oil tankers in the Strait of Hormuz and the downing of a U.S. military drone last week has put traders on edge. Symptoms of this uncertainty have been a rise in safe-haven assets like the Swiss franc, Japanese yen, and U.S. Treasury bonds, in addition to a rise in oil prices. President Trump has imposed further sanctions on Iran targeted specifically at the financial holdings of Iran’s supreme leader, Ayatollah Ali Khamenei, and eight other military leaders. However,…

The ALPS Alerian MLP ETF (AMLP) is widely known as the leading fund for gaining exposure to the biggest master limited partnerships and their high yields but I believe the Global X MLP ETF (MLPA) looks even better. The Global X MLP ETF offers a higher yield and lower expense ratio than its rival while still giving investors exposure to the MLP sector whose future outlook is looking positive. The MLPA has delivered a solid performance this year and will likely continue doing well in the future. Image courtesy of…

Finding the best ETFs is an increasingly difficult task in a world with so many to choose from. How can you pick with so many choices available? Don’t Trust ETF Labels There are at least 109 different All Cap Blend ETFs and at least 447 ETFs across twelve styles. Do investors need 37+ choices on average per style? How different can the ETFs be? Those 109 All Cap Blend ETFs are very different. With anywhere from 19 to 7672 holdings, many of these All Cap Blend ETFs have drastically different…

Biopharmaceutical company AbbVie Inc. (ABBV) has announced it will buy Botox manufacturer Allergan plc (AGN) in a cash and stock deal worth about $63 billion. The transaction value represents a 45% premium to the closing price of AbbVie’s shares of $78.45 on Monday. Allergan shareholders are set to receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share that they hold. Shares in Abbvie plunged over 10% during pre-market trading on Tuesday morning. Allergan stock on the other hand skyrocketed almost 30%. The combined company is expected to have revenue of about $48 billion. The…